Huntington's disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation

Neuroscience Letters

Volumn 507, Issue 2, 2012, Pages 127-132

  Orvoen, Sophie ^a   Pla, Patrick ^b,c,d,e   Gardier, Alain M ^a   Saudou, Frédéric ^b,c,d   David, Denis J ^a  

^a University of Paris XI   (France)

^b INSTITUT CURIE   (France)

^c CNRS   (France)

^d INSERM U1005   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Anxio depressive like behaviour; Hdh Q111 mice; Hippocampus; Huntington's disease; Neurogenesis

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; FEMALE; HIPPOCAMPUS; HUNTINGTON CHOREA; LOCOMOTION; MALE; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; ANXIETY; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; DENTATE GYRUS; DISEASE MODELS, ANIMAL; FEMALE; GENE KNOCK-IN TECHNIQUES; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEURONS;

EID: 84855302313     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.11.063     Document Type: Article

References (43)

1. Boldrini M., Underwood M.D., Hen R., Rosoklija G.B., Dwork A.J., John Mann J., Arango V. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 2009, 34:2376-2389.
2. Borrell-Pagès M., Zala D., Humbert S., Saudou F. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell. Mol. Life Sci. 2006, 63:2642-2660.
3. Cromwell H.C., Berridge K.C. Implementation of action sequences by a neostriatal site: a lesion mapping study of grooming syntax. J. Neurosci. 1996, 16:3444-3458.
4. Crook Z.R., Housman D. Huntington's disease: can mice lead the way to treatment?. Neuron 2011, 69:423-435.
5. Curtis M.A., Penney E.B., Pearson A.G., van Roon-Mom W.M.C., Butterworth N.J., Dragunow M., Connor B., Faull R.L.M. Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. PNAS 2003, 100:9023-9027.
6. David D.J., Samuels B.A., Rainer Q., Wang J.-W., Marsteller D., Mendez I., Drew M., Craig D.A., Guiard B.P., Guilloux J.-P., Artymyshyn R.P., Gardier A.M., Gerald C., Antonijevic I.A., Leonardo E.D., Hen R. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
7. Detke M.J., Johnson J., Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp. Clin. Psychopharmacol. 1997, 5:107-112.
8. Dewhurst K., Oliver J.E., McKnight A.L. Socio-psychiatric consequences of Huntington's disease. Br. J. Psychiatry 1970, 116:255-258.
9. Dorner J.L., Miller B.R., Barton S.J., Brock T.J., Rebec G.V. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease. Behav. Brain Res. 2007, 178:90-97.
10. Duff K., Paulsen J.S., Beglinger L.J., Langbehn D.R., Stout J.C. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol. Psychiatry 2007, 62:1341-1346.
11. Duman R.S. Pathophysiology of depression: the concept of synaptic plasticity. Eur. Psychiatry 2002, 17(Suppl 3):306-310.
12. Duman R.S. Depression: a case of neuronal life and death?. Biol. Psychiatry 2004, 56:140-145.
13. Fedele V., Roybon L., Nordström U., Li J.-Y., Brundin P. Neurogenesis in R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1. Neuroscience 2010, 173:76-81.
14. Gauthier L.R., Charrin B.C., Borrell-Pagès M., Dompierre J.P., Rangone H., Cordelières F.P., De Mey J., MacDonald M.E., Lessmann V., Humbert S., Saudou F. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 2004, 118:127-138.
15. Gil J.M.A.C., Mohapel P., Araújo I.M., Popovic N., Li J.-Y., Brundin P., Petersén A. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice. Neurobiol. Dis. 2005, 20:744-751.
16. Godin J.D., Colombo K., Molina-Calavita M., Keryer G., Zala D., Charrin B.C., Dietrich P., Volvert M.L., Guillemot F., Dragatsis I., Bellaiche Y., Saudou F., Nguyen L., Humbert S. Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron 2010, 67:392-406.
17. Grote H.E., Bull N.D., Howard M.L., van Dellen A., Blakemore C., Bartlett P.F., Hannan A.J. Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine. Eur. J. Neurosci. 2005, 22:2081-2088.
18. Hickey M.A., Gallant K., Gross G.G., Levine M.S., Chesselet M.-F. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing. Neurobiol. Dis. 2005, 20:1-11.
19. Holick K.A., Lee D.C., Hen R., Dulawa S.C. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 2008, 33:406-417.
20. Isingrini E., Surget A., Belzung C., Freslon J.-L., Frisbee J., O'Donnell J., Camus V., D'Audiffret A. Altered aortic vascular reactivity in the unpredictable chronic mild stress model of depression in mice: UCMS causes relaxation impairment to ACh. Physiol. Behav. 2011, 103:540-546.
21. Julien C.L., Thompson J.C., Wild S., Yardumian P., Snowden J.S., Turner G., Craufurd D. Psychiatric disorders in preclinical Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:939-943.
22. Kandasamy M., Couillard-Despres S., Raber K.A., Stephan M., Lehner B., Winner B., Kohl Z., Rivera F.J., Nguyen H.P., Riess O., Bogdahn U., Winkler J., von Hörsten S., Aigner L. Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-beta signaling in an animal model of Huntington disease. J. Neuropathol. Exp. Neurol. 2010, 69:717-728.
23. Kohl Z., Kandasamy M., Winner B., Aigner R., Gross C., Couillard-Despres S., Bogdahn U., Aigner L., Winkler J. Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease. Brain Res. 2007, 1155:24-33.
24. Lazic S.E., Grote H.E., Armstrong R.J.E., Blakemore C., Hannan A.J., van Dellen A., Barker R.A. Decreased hippocampal cell proliferation in R6/1 Huntington's mice. Neuroreport 2004, 15:811-813.
25. Lazic S.E., Grote H.E., Blakemore C., Hannan A.J., van Dellen A., Phillips W., Barker R.A. Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment. Eur. J. Neurosci. 2006, 23:1829-1838.
26. Menalled L., El-Khodor B.F., Patry M., Suárez-Fariñas M., Orenstein S.J., Zahasky B., Leahy C., Wheeler V., Yang X.W., MacDonald M., Morton A.J., Bates G., Leeds J., Park L., Howland D., Signer E., Tobin A., Brunner D. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol. Dis. 2009, 35:319-336.
27. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 1995, 15:7539-7547.
28. Page M.E., Detke M.J., Dalvi A., Kirby L.G., Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 1999, 147:162-167.
29. Pang T.Y.C., Du X., Zajac M.S., Howard M.L., Hannan A.J. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. Hum. Mol. Genet. 2009, 18:753-766.
30. Peng Q., Masuda N., Jiang M., Li Q., Zhao M., Ross C.A., Duan W. The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model. Exp. Neurol. 2008, 210:154-163.
31. Phillips W., Morton A.J., Barker R.A. Abnormalities of neurogenesis in the R6/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment. J. Neurosci. 2005, 25:11564-11576.
32. Pouladi M.A., Graham R.K., Karasinska J.M., Xie Y., Santos R.D., Petersén A., Hayden M.R. Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain 2009, 132:919-932.
33. Revest J.-M., Dupret D., Koehl M., Funk-Reiter C., Grosjean N., Piazza P.-V., Abrous D.N. Adult hippocampal neurogenesis is involved in anxiety-related behaviors. Mol. Psychiatry 2009, 14:959-967.
34. Santarelli L., Saxe M., Gross C., Surget A., Dulawa S.C., Battaglia F., Weisstaub N., Lee J., Duman R.S., Arancio O., Belzung C., Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
35. Simpson J.M., Gil-Mohapel J., a Pouladi M., Ghilan M., Xie Y., Hayden M.R., Christie B.R. Altered adult hippocampal neurogenesis in the yac128 transgenic mouse model of huntington disease. Neurobiol. Dis. 2011, 41:249-260.
36. Szapacs M.E., Mathews T.A., Tessarollo L., Ernest Lyons W., Mamounas L.A., Andrews A.M. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. J. Neurosci. Methods 2004, 140:81-92.
37. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
38. van Duijn E., Reedeker N., Giltay E.J., Roos R.A.C., van der Mast R.C. Correlates of apathy in Huntington's disease. J. Neuropsychiatry Clin. Neurosci. 2010, 22:287-294.
39. Wang J.-W., David D.J., Monckton J.E., Battaglia F., Hen R. Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J. Neurosci. 2008, 28:1374-1384.
40. Wheeler V.C. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum. Mol. Genet. 1999, 8:115-122.
41. Wheeler V.C., White J.K., Gutekunst C.-A., Vrbanac V., Weaver M., Li X.-J., Vonsattel J.-P., Gusella J.F., Hersch S., Auerbach W., MacDonald M.E., Joyner A.L. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum. Mol. Genet. 2000, 9:503-513.
42. Wheeler V.C., Gutekunst C.-A., Vrbanac V., Lebel L.-A., Schilling G., Hersch S., Friedlander R.M., Gusella J.M., Vonsattel J.-P., Borchelt D.R., MacDonald M.E. Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum. Mol. Genet. 2002, 11:633-640.
43. Winner B., Kohl Z., Gage F.H. Neurodegenerative disease and adult neurogenesis. Eur. J. Neurosci. 2011, 33:1139-1151.